Eric Lang - 14 Jun 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Chief Medical Officer
Signature
/s/ Eric Lang
Issuer symbol
CHRO
Transactions as of
14 Jun 2024
Net transactions value
$0
Form type
4
Filing time
18 Jun 2024, 20:05:13 UTC
Previous filing
15 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRO Stock Option Award +130,000 +537% 154,223 14 Jun 2024 Common Stock 130,000 $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 14, 2024, the Reporting Person was granted stock options to purchase 130,000 shares of common stock at an exercise price of $1.30 per share, which shall vest on a quarterly basis over a period of two (2) years.